Dendreon Corporation to Present at 3rd Annual Cancer Immunotherapy Conference in New York
SEATTLE--(BUSINESS WIRE)--October 3, 2012 – Dendreon Corporation (NASDAQ:DNDN) today announced the company will be presenting at the MD Becker Partners’ 3rd Annual Cancer Immunotherapy: A Long-Awaited Reality conference taking place from 8:00 a.m. to 6:30 p.m. EDT on October 4, 2012, at the New York Academy of Medicine in New York.